- Coordinator
- Universiteit Gent, Belgium
- Runs
- 1 June 2025 to 31 May 2029
- Status
- Running
- EU funding
- €5.5m
- Total cost
- €5.5m
- Partners
- 7 organisations in 5 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101190685
What the project is doing
In the project's own words, from its summary on CORDIS.
Control of soil transmitted helminths (STH) and Schistosomiasis (SCH) has been part of routine programmes for many years, yet, the efficacy and effectiveness of these programmes is challenged by low and failing drug efficacy and growing concerns of anthelmintic resistance, calling for a revision of the MDA-drug strategies. In this regard, the novel fixed-dose co-formulation (FDC) including albendazole and ivermectin has proven to be safe and to overcome most of the challenges in drug efficacy for STH.
For T. solium the situation is very different from STH and SCH as currently there are no countries routinely implementing control. 3SI-CONTROL will assess the safety and cost-effectiveness of the FDC co-administration with praziquantel in reducing the prevalence of T. solium, STH and SCH, in a randomised controlled trial embedded in solid implementation research. Results from 3SI-CONTROL will thereby provide a scientific evidence base on the safety and effectiveness of integration of T. solium control with STH and SCH, considering the One Health approach.
Beyond this, the substantial implementation research component will enable bridging the gap between the evidence-based practice (results on safety and effectiveness) and the actual implementation in the routine, real-world setting. These results, joined by a comprehensive dissemination and advocacy plan, will provide leverage to stimulate uptake of T. solium in the existing routine NTD control programmes, enabling the implementation of a safe and integrated control strategy with a higher effectiveness, tackling three top ranking NTDs.
By harnessing advanced concepts in One Health, implementation research, and pharmacovigilance, our project aims to deliver transformative impacts in NTD control, reducing the individual, social and economic burdens of resource poor rural populations.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universiteit Gent | Gent | Belgium | Coordinator |
| Fundacion Privada Instituto De Salud Global Barcelona | Barcelona | Spain | Participant |
| Hospital Clinic De Barcelona | Barcelona | Spain | Third party |
| Fundacao Manhica | Vila Da Manhica Maputo | MZ | Participant |
| Sokoine University of Agriculture | Morogoro | TZ | Participant |
| University of Dar Es Salaam | Dar Es Salaam | TZ | Participant |
| University of Zambia | Lusaka | ZM | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI